SCHEMBL1668262

SCHEMBL1668262

CS(=O)(=O)N1CCC(c2cc(F)c(OC3CCN(Cc4ccc(C(F)(F)F)cc4)C3)c(F)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
KCNH2 Q12809 5/20 0.42
GPR119 Q8TDV5 5/20 0.42
TEAD1 P28347 2/20 0.40
CCR3 P51677 1/20 0.40
KMT2A Q03164 2/20 0.39
LMNA P02545 1/20 0.39
RORC P51449 2/20 0.39
ADRB2 P07550 1/20 0.39
PIK3CA P42336 1/20 0.39
PRKAA2 P54646 1/20 0.39
CYP2D6 P10635 1/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38
BCHE P06276 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12198321 0.94 KDM4E (0.52) KDM4EALDH1A1KCNH2GPR119TEAD1
SCHEMBL1668410 0.94 KDM4E (0.49) KDM4EALDH1A1KCNH2GPR119CCR3
SCHEMBL1668787 0.91 KDM4E (0.51) KDM4EALDH1A1KCNH2GPR119TEAD1
SCHEMBL1668617 0.88 KDM4E (0.41) KDM4EALDH1A1KCNH2GPR119KMT2A
SCHEMBL12198265 0.87 KDM4E (0.41) KDM4EALDH1A1KCNH2GPR119KMT2A
SCHEMBL1668765 0.86 KDM4E (0.40) KDM4EALDH1A1KCNH2GPR119KMT2A
SCHEMBL12198419 0.86 ADRB2 (0.46) KDM4EALDH1A1TEAD1ADRB2BCHE
SCHEMBL1670868 0.85 KDM4E (0.43) KDM4EALDH1A1KMT2ALMNARORC
SCHEMBL1671394 0.85 EPHX2 (0.46) KDM4EALDH1A1KCNH2GPR119LMNA
SCHEMBL1670840 0.84 TEAD1 (0.38) KDM4EALDH1A1KCNH2GPR119TEAD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575168-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2013-11-05 US claimed
EP-2486033-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2012-08-15 EP claimed
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-10-06 US claimed
WO-2011044001-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-04-14 WO claimed
US-8575168-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2013-11-05 US disclosed
EP-2486033-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2012-08-15 EP disclosed
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-10-06 US disclosed
WO-2011044001-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY GPR119, GPR65, GPR39 KDM4E 3454/4885ALDH1A1 2341/4885KCNH2 1979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.